Document is current
Any future updates will be listed below
-
Authors
Claxton, Scott
Porter, Paul http://orcid.org/0000-0001-9051-589X
Brisbane, Joanna http://orcid.org/0000-0003-3364-5414
Bear, Natasha
Wood, Javan
Peltonen, Vesa
Della, Phillip
Smith, Claire
Abeyratne, Udantha
- License Information
-
More Information
Article History
Received: 10 December 2020
Accepted: 8 June 2021
First Online: 2 July 2021
Change Date: 22 July 2021
Change Type: Update
Change Details: The original version of this Article contained an error in the email address of the corresponding author Paul Porter. This has now been corrected in both the PDF and HTML versions of the Article.
Competing interests
: ResApp Health provided funding to support the Breathe Easy Program at JHC and UQ. Joondalup Health Campus provided office space, IT services, and consumables in kind. P.P., S.C. and U.A. are scientific advisors of ResApp Health (RAP). P.P. and U.A. are shareholders in RAP. U.A. was RAP’s Chief Scientist. RAP is an Australian publicly listed company commercializing the technology under license from the University of Queensland, where U.A. is employed. U.A. is a named inventor of the UQ technology. V.S. and J.W. are employees of ResApp Health. N.B., J.B., C.S. and P.D. declare no competing interests.
